The global burden of melanoma: results from the Global Burden of Disease Study 2015
British Journal of Dermatology2017Vol. 177(1), pp. 134–140
Citations Over TimeTop 1% of 2017 papers
Chanté Karimkhani, A. C. Green, Tamar Nijsten, Martin A. Weinstock, Robert P. Dellavalle, Mohsen Naghavi, Christina Fitzmaurice
Abstract
The greatest burden from melanoma falls on Australasian, North American, European, elderly and male populations, which is consistent with previous investigations. These substantial disparities in melanoma burden worldwide highlight the need for aggressive prevention efforts. The Global Burden of Disease Study results can help shape melanoma research and public policy.
Related Papers
- → Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010(2012)8,965 cited
- → The burden of disease in Germany at the national and regional level—results in terms of disability-adjusted life years (DALY) from the BURDEN 2020 study(2022)37 cited
- → Measuring burden of disease in two inner London boroughs using Disability Adjusted Life Years(2008)31 cited
- → Disability-Adjusted Life Years (DALYs) for Injuries Using Death Certificates and Hospital Discharge Survey by the Korean Burden of Disease Study 2012(2016)21 cited
- → Neurological diseases in Peru: a systematic analysis of the global burden disease study(2020)15 cited